Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | SELL | P14151 | 1/20 | 0.32 |
| ▸ | SELP | P16109 | 1/20 | 0.32 |
| ▸ | SELE | P16581 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20590549 | 0.79 | ACHE (0.43) | ACHECYP3A4SELLSELPSELE | |
| SCHEMBL10730717 | 0.79 | SELL (0.43) | ACHECYP3A4SELLSELPSELE | |
| SCHEMBL395719 | 0.72 | — | — | |
| SCHEMBL28084558 | 0.72 | TDP1 (0.48) | ACHECYP3A4 | |
| SCHEMBL27887395 | 0.70 | — | — | |
| SCHEMBL3340131 | 0.68 | — | — | |
| SCHEMBL15351577 | 0.68 | — | — | |
| SCHEMBL15352080 | 0.68 | HDAC1 (0.31) | — | |
| SCHEMBL5847851 | 0.68 | CA1 (0.43) | ACHECYP3A4SELLSELPSELE | |
| SCHEMBL28040377 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0513543-B1 | Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them. | BEHRINGWERKE AG (DE) | 1995-10-25 | — | — | EP | claimed |
| US-5457114-A | Antithrombin; antithrombotic, enzyme resistance, tolerability | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1995-10-10 | — | — | US | claimed |
| EP-0513543-A1 | Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them. | BEHRINGWERKE Aktiengesellschaft (DE) | 1992-11-19 | — | — | EP | claimed |
| WO-2020009016-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | ユニチカ株式会社 | 2020-01-09 | — | — | WO | disclosed |
| CN-108017791-A | Polyphenylene ether powder and manufacture method | 旭化成株式会社 | 2018-05-11 | — | — | CN | disclosed |
| CN-107177043-A | Polyphenylene ether powder and manufacture method with slight void | 旭化成株式会社 | 2017-09-19 | — | — | CN | disclosed |
| WO-2014121036-A1 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | DEUTERX, LLC (US) | 2014-08-07 | — | — | WO | disclosed |
| US-20140221369-A1 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | DEUTERX, LLC (US) | 2014-08-07 | — | — | US | disclosed |
| CN-103421181-A | Production method for polyphenylene ether powder | ASAHI KASEI CHEMICALS CORP | 2013-12-04 | — | — | CN | disclosed |
| CN-103421178-A | Production method for polyphenylene ether powder | ASAHI KASEI CHEMICALS CORP | 2013-12-04 | — | — | CN | disclosed |
| CN-103421182-A | Production method for polyphenylene ether powder | ASAHI KASEI CHEMICALS CORP | 2013-12-04 | — | — | CN | disclosed |
| EP-0658585-B1 | Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants | STUEBER WERNER (DE) | 2000-07-19 | — | — | EP | disclosed |
| CN-1039125-C | Amidinophenylalanine derivatives and process for preparing same and use | REHRINGWERKE AG (DE) | 1998-07-15 | — | — | CN | disclosed |
| US-5627283-A | ANTITHROMBIN COMPOUNDS | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1997-05-06 | — | — | US | disclosed |
| US-5571844-A | Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1996-11-05 | — | — | US | disclosed |
| EP-0513543-B1 | Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them. | BEHRINGWERKE AG (DE) | 1995-10-25 | — | — | EP | disclosed |
| US-5457114-A | Antithrombin; antithrombotic, enzyme resistance, tolerability | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1995-10-10 | — | — | US | disclosed |
| EP-0658585-A2 | Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants | BEHRINGWERKE Aktiengesellschaft (DE) | 1995-06-21 | — | — | EP | disclosed |
| CN-1067249-A | Amidinophenylalaninederivatives derivatives and Preparation Method And The Use | BEHRINGWERKE AG (DE) | 1992-12-23 | — | — | CN | disclosed |
| EP-0513543-A1 | Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them. | BEHRINGWERKE Aktiengesellschaft (DE) | 1992-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221369-A1 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | SRD5A2, PPARD, SRD5A1 | ACHE 4635/4885CYP3A4 134/4885SELL 3824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.